Earnings ·
Merit Medical raises full-year revenue guidance to $1.64B and acquires Solo Pace for $45M
MMSIMerit Medical Systems Inc
Merit Medical Systems reported third-quarter revenue of $416.2 million, an 8% increase year-over-year, with non-GAAP earnings per share rising 22% to $1.12. The company raised its full-year 2026 revenue guidance to a range of $1.635 billion to $1.642 billion and updated its non-GAAP EPS outlook to $4.33–$4.37. Concurrently, Merit completed the acquisition of Solo Pace for approximately $45 million in cash, expanding its cardiac therapies platform with TAVR pacing technology. Merit Medical Systems is a global manufacturer and marketer of healthcare technology.